Bettelheim K.A. 2007. The non-O157 Shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens. Crit. Rev. Microbiol. 33:67-87.

Bielaszewska M, H. Karch. 2005. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb. Haemost. 94:312-318.

Bielaszewska M., U. Dobrindt, J. Gartner, I. Gallitz, J. Hacker, H. Karch, D. Muller, S. Schubert, A.M. Schmidt, L.J. Sorsa, J. Zdziarski. 2007. Aspects of genome plasticity in pathogenic Escherichia coli. Int. J. Med. Microbiol. 297:625-639.

Gyles C.L. 2007. Shiga toxin-producing Escherichia coli: an overview. J. Anim. Sci. 85(Suppl):E45-62.

Johnson K.E., C.M. Thorpe, C.L. Sears. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595.

Karch H., P.I. Tarr, M. Bielaszewska. 2005. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295:405-418.

Karch H., A.W. Friedrich, A. Gerber, L.B. Zimmerhackl, M.A. Schmidt, M. Bielaszewska. 2006. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin. Thromb. Haemost. 32:105-112.

Karmali M.A. 2004. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol. Biotechnol. 26:117-122.

Tarr P.I., C.A. Gordon, W.L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 365:1073-1086.